Carmel, IN, United States of America

Chakravarthy N N Narasimhan

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chakravarthy N N Narasimhan. Retrieved from https://idiyas.com/inventor/chakravarthy-n-n-narasimhan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chakravarthy N N Narasimhan

Introduction

Chakravarthy N N Narasimhan is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents for diabetes and obesity.

Latest Patents

One of his key inventions is related to glucagon-like peptide-1 crystals. This patent provides individual tetragonal flat rod-shaped or plate-like crystals of glucagon-like peptide-1 related molecules. The invention includes processes for their preparation, compositions, and methods of use. The crystal preparations exhibit extended time action in vivo and are useful for treating diabetes, obesity, and related conditions. He holds 1 patent in this area.

Career Highlights

Chakravarthy is associated with Eli Lilly and Company, a leading pharmaceutical company known for its innovative solutions in healthcare. His work at Eli Lilly has focused on advancing treatments that can significantly improve patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Ronald Norbert Hermeling and James A Hoffmann, contributing to a dynamic research environment that fosters innovation.

Conclusion

Chakravarthy N N Narasimhan's work exemplifies the impact of innovative research in the pharmaceutical industry, particularly in addressing critical health issues like diabetes and obesity. His contributions continue to pave the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…